[HCV nosocomial infections in hemodialysis].

PubWeight™: 0.80‹?›

🔗 View Article (PMID 11675284)

Published in Ann Biol Clin (Paris) on October 01, 2001

Authors

J Izopet1, K Sandres-Sauné, G Salama, C Pasquier, J Puel, L Rostaing

Author Affiliations

1: Laboratoire de virologie, CHU Toulouse, France.

Articles by these authors

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant (2010) 5.40

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet (1995) 4.65

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med (1987) 4.38

Voltage-sensitive dyes reveal a modular organization in monkey striate cortex. Nature (1986) 3.79

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26

Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant (2009) 3.19

Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97

The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37

Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol (2000) 2.35

Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res (2000) 1.97

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation. Am J Transplant (2007) 1.76

Optical mapping of repolarization and refractoriness from intact hearts. Circulation (1994) 1.75

Cytoplasmic pH Regulation in Acer pseudoplatanus Cells: I. A P NMR Description of Acid-Load Effects. Plant Physiol (1986) 1.71

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Prog Urol (2009) 1.67

Cytoplasmic pH Regulation in Acer pseudoplatanus Cells: II. Possible Mechanisms Involved in pH Regulation during Acid-Load. Plant Physiol (1986) 1.66

Optical mapping of atrioventricular node reveals a conduction barrier between atrial and nodal cells. Am J Physiol (1998) 1.60

A naphthyl analog of the aminostyryl pyridinium class of potentiometric membrane dyes shows consistent sensitivity in a variety of tissue, cell, and model membrane preparations. J Membr Biol (1992) 1.59

Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium (1997) 1.56

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology (1997) 1.55

Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods (2003) 1.54

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50

FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia. Am J Transplant (2006) 1.45

Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study. Am J Transplant (2006) 1.44

Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43

Maps of optical action potentials and NADH fluorescence in intact working hearts. Am J Physiol (1987) 1.43

Clinical and angiographic results of angioplasty with a paclitaxel-eluting stent for unprotected left main coronary artery disease (a study of 101 consecutive patients). Arch Cardiovasc Dis (2008) 1.39

The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res (2001) 1.38

Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37

HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods (2001) 1.36

Merocyanine 540 as an optical probe of transmembrane electrical activity in the heart. Science (1976) 1.33

Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32

Optical probes of membrane potential in heart muscle. J Physiol (1979) 1.30

Acute hepatitis E in south-west France over a 5-year period. J Clin Virol (2008) 1.29

Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant (2008) 1.24

Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant (2010) 1.23

Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation (2001) 1.22

Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation. Am J Transplant (2011) 1.20

Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology. Acta Virol (1988) 1.20

Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med (1998) 1.18

"T"-shaped stent placement: a technique for the treatment of dissected bifurcation lesions. Cathet Cardiovasc Diagn (1996) 1.17

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis (1997) 1.17

Reactive disulfides trigger Ca2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem (1989) 1.16

Optical mapping reveals that repolarization spreads anisotropically and is guided by fiber orientation in guinea pig hearts. Circ Res (1995) 1.15

Fluorescence measurement of calcium transients in perfused rabbit heart using rhod 2. Am J Physiol (1998) 1.14

Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. J Virol (2000) 1.14

Activation and repolarization patterns are governed by different structural characteristics of ventricular myocardium: experimental study with voltage-sensitive dyes and numerical simulations. J Cardiovasc Electrophysiol (1996) 1.14

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group. AIDS (1999) 1.12

Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1. J Virol (1995) 1.12

Sulfhydryl oxidation induces rapid calcium release from sarcoplasmic reticulum vesicles. J Biol Chem (1986) 1.11

Effects of cardiac work on electrical potential gradient across mitochondrial membrane in perfused rat hearts. Am J Physiol (1993) 1.11

Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood (1994) 1.10

Critical sulfhydryls regulate calcium release from sarcoplasmic reticulum. J Bioenerg Biomembr (1989) 1.09

Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease: results from the French Monocentric Study. Circulation (1997) 1.09

Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA. J Virol Methods (1999) 1.09

Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy. J Clin Microbiol (1998) 1.08

Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08

[Study of CD45 isoforms on T CD8 lymphocytes, in the peripheral blood and the graft in patients after kidney transplantation]. Presse Med (1992) 1.08

Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. Am J Transplant (2006) 1.07

Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand (1989) 1.06

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer (1999) 1.05

Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol (2003) 1.05

Heavy metals induce rapid calcium release from sarcoplasmic reticulum vesicles isolated from skeletal muscle. Proc Natl Acad Sci U S A (1983) 1.05

Acute renal failure following liver transplantation with induction therapy. Clin Nephrol (2006) 1.04

Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine. J Med Virol (1999) 1.03

How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant (2013) 1.03

Thimerosal interacts with the Ca2+ release channel ryanodine receptor from skeletal muscle sarcoplasmic reticulum. J Biol Chem (1995) 1.01

Silver ions trigger Ca2+ release by acting at the apparent physiological release site in sarcoplasmic reticulum. J Biol Chem (1984) 1.01

High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients. Tumour Biol (2000) 1.01

High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant (2010) 1.01

Repolarization inhomogeneities in ventricular myocardium change dynamically with abrupt cycle length shortening. Circulation (1991) 1.01

Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun (1991) 1.01

Focal adhesion kinase regulation by oxidative stress in different cell types. IUBMB Life (2001) 0.99

Influence of pregnancy on human immunodeficiency virus disease. Eur J Obstet Gynecol Reprod Biol (1990) 0.99

Hepatitis C virus infection in French hemodialysis units: a multicenter study. J Med Virol (2000) 0.99

Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic Biol Med (1998) 0.99

Hepatitis C virus-related kidney disease: an overview. Clin Nephrol (2008) 0.99

Suppression of MR gradient artefacts on electrophysiological signals based on an adaptive real-time filter with LMS coefficient updates. MAGMA (2005) 0.98

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation (1995) 0.97

Isolated aneurysm of the left sinus of Valsalva. Rupture into the left atrium, left ventricle and dynamic coronary constriction. J Cardiovasc Surg (Torino) (1990) 0.96

Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum. J Biol Chem (1988) 0.96

Improvement of the Cockcroft-Gault equation for predicting glomerular filtration in cancer patients. Bull Cancer (1998) 0.95

Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplant (2012) 0.95

Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int (2006) 0.95

Differential upregulation of cellular adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis. J Surg Res (2001) 0.95

Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. J Infect Dis (2004) 0.95

Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol (2007) 0.95

A pharmacokinetic model for alpha interferon administered subcutaneously. Br J Clin Pharmacol (1999) 0.95

Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes. Am J Transplant (2013) 0.94

Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency. Nephron (1994) 0.94

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen. AIDS (2000) 0.94